These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12684293)

  • 21. CCR1 and CCR5 expression on inflammatory cells is related to cigarette smoking and chronic obstructive pulmonary disease severity.
    Wang F; He B
    Chin Med J (Engl); 2012 Dec; 125(23):4277-82. PubMed ID: 23217400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD.
    Russell KE; Chung KF; Clarke CJ; Durham AL; Mallia P; Footitt J; Johnston SL; Barnes PJ; Hall SR; Simpson KD; Starkey MR; Hansbro PM; Adcock IM; Wiegman CH
    PLoS One; 2016; 11(1):e0146102. PubMed ID: 26752192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
    Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
    COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).
    Wang J; Urbanowicz RA; Tighe PJ; Todd I; Corne JM; Fairclough LC
    PLoS One; 2013; 8(3):e58556. PubMed ID: 23505535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers.
    Willemse BW; ten Hacken NH; Rutgers B; Lesman-Leegte IG; Postma DS; Timens W
    Eur Respir J; 2005 Nov; 26(5):835-45. PubMed ID: 16264044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
    Keatings VM; Collins PD; Scott DM; Barnes PJ
    Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD.
    Chrysofakis G; Tzanakis N; Kyriakoy D; Tsoumakidou M; Tsiligianni I; Klimathianaki M; Siafakas NM
    Chest; 2004 Jan; 125(1):71-6. PubMed ID: 14718423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of the CD163-Haptoglobin Axis in the Airways of COPD Patients.
    Higham A; Baker JM; Jackson N; Shah R; Lea S; Singh D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in responses upon corticosteroid therapy between smoking and non-smoking patients with COPD.
    Van Overveld FJ; Demkow U; Górecka D; De Backer WA; Zieliński J
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():273-82. PubMed ID: 17072055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indoor particulate matter exposure is associated with increased black carbon content in airway macrophages of former smokers with COPD.
    Belli AJ; Bose S; Aggarwal N; DaSilva C; Thapa S; Grammer L; Paulin LM; Hansel NN
    Environ Res; 2016 Oct; 150():398-402. PubMed ID: 27372063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
    Glader P; von Wachenfeldt K; Löfdahl CG
    Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids.
    Telenga ED; Hoffmann RF; Ruben t'Kindt ; Hoonhorst SJ; Willemse BW; van Oosterhout AJ; Heijink IH; van den Berge M; Jorge L; Sandra P; Postma DS; Sandra K; ten Hacken NH
    Am J Respir Crit Care Med; 2014 Jul; 190(2):155-64. PubMed ID: 24871890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease.
    Rutgers SR; van der Mark TW; Coers W; Moshage H; Timens W; Kauffman HF; Koëter GH; Postma DS
    Thorax; 1999 Jul; 54(7):576-80. PubMed ID: 10377200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD).
    Eapen MS; Hansbro PM; McAlinden K; Kim RY; Ward C; Hackett TL; Walters EH; Sohal SS
    Sci Rep; 2017 Oct; 7(1):13392. PubMed ID: 29042607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of incremental exercise on airway and systemic inflammation in patients with COPD.
    Davidson WJ; Verity WS; Traves SL; Leigh R; Ford GT; Eves ND
    J Appl Physiol (1985); 2012 Jun; 112(12):2049-56. PubMed ID: 22500008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
    Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
    Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers.
    Singh D; Fox SM; Tal-Singer R; Plumb J; Bates S; Broad P; Riley JH; Celli B;
    Thorax; 2011 Jun; 66(6):489-95. PubMed ID: 21441172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers.
    Santini G; Mores N; Shohreh R; Valente S; Dabrowska M; Trové A; Zini G; Cattani P; Fuso L; Mautone A; Mondino C; Pagliari G; Sala A; Folco G; Aiello M; Pisi R; Chetta A; Losi M; Clini E; Ciabattoni G; Montuschi P
    J Breath Res; 2016 Jan; 10(1):017102. PubMed ID: 26814886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.
    Traves SL; Culpitt SV; Russell RE; Barnes PJ; Donnelly LE
    Thorax; 2002 Jul; 57(7):590-5. PubMed ID: 12096201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.